mRNA-Based Vaccination Drives in Vivo Dendritic Cell Reprogramming and Selective Cytotoxic T Lymphocyte Modulation for Enhanced Antitumor Immunity

Journal:

ACS Nano

Published:

2025-10-28

DOI:

10.1021/acsnano.5c09365

Affiliations:

4

Authors:

6

Go to article

Institutions	Authors	Share
National Key Laboratory of Innovative Immunotherapy, China	3.500000	0.58
New Jersey Institute of Technology (NJIT), United States of America (USA)	2.000000	0.33
National Center of Technology Innovation for Biopharmaceuticals (NCITB), China	0.500000	0.08

Interested in Immunology?